Pages that link to "Q40779398"

The following pages link to Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines (Q40779398):

Displaying 41 items.

• Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China (Q30411253) (← links)
• The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodents (Q34222406) (← links)
• Genetic and structural determinants of virus neutralizing antibodies. (Q34303121) (← links)
• The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors (Q34313957) (← links)
• Influence of maternal antibodies on neonatal immunization against respiratory viruses. (Q34398563) (← links)
• An unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses (Q34479840) (← links)
• Maternal vaccination: moving the science forward (Q34630952) (← links)
• A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus (Q35127300) (← links)
• Immunology of viral respiratory tract infection in infancy (Q35131864) (← links)
• Nonsegmented negative-strand viruses as vaccine vectors (Q35139219) (← links)
• Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years (Q35566601) (← links)
• New generation live vaccines against human respiratory syncytial virus designed by reverse genetics (Q36237057) (← links)
• Need for a safe vaccine against respiratory syncytial virus infection. (Q36266896) (← links)
• Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection (Q36463070) (← links)
• Viral and host factors in human respiratory syncytial virus pathogenesis (Q36483836) (← links)
• Immunopathology of RSV infection: prospects for developing vaccines without this complication (Q36605119) (← links)
• The role of maternal antibodies in the emergence of severe disease as a result of fragmentation (Q36638922) (← links)
• An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats (Q36949797) (← links)
• RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response. (Q36994716) (← links)
• Understanding the mechanisms of viral induced asthma: new therapeutic directions (Q37072079) (← links)
• Neonatal immunization with respiratory syncytial virus glycoprotein fragment induces protective immunity in the presence of maternal antibodies in mice (Q37086092) (← links)
• Respiratory syncytial virus--a comprehensive review (Q38098094) (← links)
• Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice (Q39094870) (← links)
• Influence of respiratory syncytial virus strain differences on pathogenesis and immunity (Q39289416) (← links)
• Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambs (Q40890942) (← links)
• Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants (Q41151191) (← links)
• Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses: evidence for epitope masking and decreased localization of antigen in the spleen (Q43287068) (← links)
• Comparison of strain-specific antibody responses during primary and secondary infections with respiratory syncytial virus (Q43520192) (← links)
• The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years (Q45323691) (← links)
• Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice. (Q45324151) (← links)
• Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy (Q45491056) (← links)
• Maternally transferred anti-factor VIII IgG reduce the anti-factor VIII humoral immune response in factor VIII-deficient mice. (Q45862501) (← links)
• Mucosal immunisation and immunoprophylaxis as potential strategies for prevention of SARS. (Q47284003) (← links)
• Early life interventions to prevent allergy in the offspring: the role of maternal immunization and postnatal mucosal allergen exposure (Q51354669) (← links)
• Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine (Q51986192) (← links)
• Respiratory syncytial virus vaccine development (Q56481283) (← links)
• Progress in Respiratory Virus Vaccine Development (Q56894869) (← links)
• The convalescent sera option for containing COVID-19 (Q90296531) (← links)
• Impact of Respiratory Syncytial Virus Infection on the Host Cell: Implications for Antiviral Strategies (Q90681995) (← links)
• Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19 (Q95602961) (← links)
• A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19 (Q99372497) (← links)